BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Policy

  The Philippines Suspends Sanofi’s Dengue Vaccine After 730,000+ Children are Immunized

  Sanofi said the analysis showed more cases of severe disease could occur following vaccination in patients who had not been previously infected by the dengue virus.

  December 4, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Biotech Bay

  2 Biotechs Under $5 Bucks Investors Should Put on Their Watchlists

  Why investors may want to keep an eye on Idera Pharmaceuticals and Ekso Bionics.

  December 4, 2017

   · 

  1 min read
• 

  Biotech Bay

  2 Bay Area Biotechs Expected to Grow 67% or Up Over the Next Five Years

  A look at two life science companies that are expected to grow more than 67 percent over the next five years.

  December 4, 2017

   · 

  2 min read

   · 

  Mark Terry
• Business

  12 Sigma, a US-China Startup, Raises $30M for AI-Imaging

  12 Sigma Technologies, a San Diego medical imaging firm founded by a team of Chinese scientists, raised $30M in a B round led by China VC firm SBCVC.

  December 4, 2017

   · 

  1 min read
• 

  Biotech Beach

  4 Solid Biotechs to Load Up on This Month

  Barring a huge meltdown, the S&P 500 will once again have a double-digit year of gains, and most investors should be looking at their 401(k)s and other accounts with some added holiday cheer.

  December 4, 2017

   · 

  1 min read
• 

  Policy

  CareFusion Issues Warning to Customers Over Alaris Syringe Pump Alarm

  The company warns that pumps made before 2008 may display an error message that could stop the pump from working.

  December 4, 2017

   · 

  1 min read
• Drug Development

  BioLineRx Reports Overall Survival Results From Long-Term Follow-Up of Phase IIa Trial in r/r AML

  The results demonstrate that the combination of BL-8040 with HiDAC in this difficult-to-treat patient population significantly improved overall survival, compared with historical data of HiDAC monotherapy.

  December 4, 2017

   · 

  6 min read
• Genetown

  ProMIS Neurosciences Announces Trading on OTCQB Venture Market

  ProMIS Neurosciences common shares will continue to trade on the Toronto Stock Exchange.

  December 4, 2017

   · 

  3 min read
• 

  Bio NC

  Top 20 Life Science Startups to Watch in 2018

  BioSpace is proud to present its NextGen “Class of 2018,” a list of 20 up-and-coming life science companies in North America that started up no earlier than 2015.

  December 4, 2017

   · 

  9 min read

   · 

  Mark Terry
• 

  Business

  What You Need to Know About BlueRock Therapeutics

  BlueRock Therapeutics, which has locations in Toronto, NYC and Cambridge, Mass., rocketed to existence in December 2016 with $225M in venture funding to focus on regenerative medicine, using iPSC therapies.

  December 4, 2017

   · 

  8 min read

   · 

  Mark Terry